Health
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store – Yahoo News Australia
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from…
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full-strength doses were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full-strength dose to follow — that one was 90% effective.
Oxford’s results may not have…
-
Business6 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business21 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
Noosa News20 hours agoMajor flood arrives at Birdsville
-
Noosa News14 hours agoPolice investigate Bulimba park assault following scooter dispute